Alassane-Kpembi, I., et al. New insights into mycotoxin mixtures: the toxicity of low doses of Type B trichothecenes on intestinal epithelial cells is synergistic. Toxicol. Appl. Pharmacol. 272:1 (2013), 191–198.
Bensassi, F., et al. In vitro investigation of toxicological interactions between the fusariotoxins deoxynivalenol and zearalenone. Toxicon 84 (2014), 1–6.
Bravin, F., et al. In vitro cytochrome p450 formation of a mono-hydroxylated metabolite of zearalenone exhibiting estrogenic activities: possible occurrence of this metabolite in vivo. Int. J. Mol. Sci. 10:4 (2009), 1824–1837.
Cortinovis, C., et al. Fusarium mycotoxins: effects on reproductive function in domestic animals–a review. Theriogenology 80:6 (2013), 557–564.
Diamanti-Kandarakis, E., et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 30:4 (2009), 293–342.
Eriksen, G.S., Pettersson, H., Lindberg, J.E., Absorption, metabolism and excretion of 3-acetyl DON in pigs. Arch. Tierernahr 57:5 (2003), 335–345.
Ermler, S., Scholze, M., Kortenkamp, A., The suitability of concentration addition for predicting the effects of multi-component mixtures of up to 17 anti-androgens with varied structural features in an in vitro AR antagonist assay. Toxicol. Appl. Pharmacol. 257:2 (2011), 189–197.
Evans, R.M., Scholze, M., Kortenkamp, A., Additive mixture effects of estrogenic chemicals in human cell-based assays can be influenced by inclusion of chemicals with differing effect profiles. PLoS One, 7(8), 2012, e43606.
FAO/WHO, J., Expert Committee on Food Additives. WHO Technical Report Series, 959, 2011, 37–48.
Frizzell, C., et al. Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis. Toxicol. Lett. 206:2 (2011), 210–217.
Frizzell, C., et al. An in vitro investigation of endocrine disrupting effects of the mycotoxin alternariol. Toxicol. Appl. Pharmacol. 271:1 (2013), 64–71.
Frizzell, C., et al. Endocrine disrupting effects of ochratoxin A at the level of nuclear receptor activation and steroidogenesis. Toxicol. Lett. 217:3 (2013), 243–250.
Fung, F., Clark, R.F., Health effects of mycotoxins: a toxicological overview. J. Toxicol. Clin. Toxicol. 42:2 (2004), 217–234.
Gijsbers, L., et al. Stable reporter cell lines for peroxisome proliferator-activated receptor gamma (PPARgamma)-mediated modulation of gene expression. Anal. Biochem. 414:1 (2011), 77–83.
Grenier, B., Oswald, I.P., Mycotoxin co-contamination of food and feed: meta-analysis of publications describing toxicological interactions. World Mycotoxin J. 4 (2011), 285–313.
Houtman, C.J., et al. Biological validation of a sample preparation method for ER-CALUX bioanalysis of estrogenic activity in sediment using mixtures of xeno-estrogens. Environ. Sci. Technol. 40:7 (2006), 2455–2461.
Huybrechts, B., et al. Fast and sensitive LC-MS/MS method measuring human mycotoxin exposure using biomarkers in urine. Arch. Toxicol. 89:11 (2014), 1993–2005.
Kjaerstad, M.B., et al. Mixture effects of endocrine disrupting compounds in vitro. Int. J. Androl. 33:2 (2010), 425–433.
Kuiper-Goodman, T., Scott, P.M., Watanabe, H., Risk assessment of the mycotoxin zearalenone. Regul. Toxicol. Pharmacol. 7:3 (1987), 253–306.
Leesnitzer, L.M., et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:21 (2002), 6640–6650.
Lehmann, L., Wagner, J., Metzler, M., Estrogenic and clastogenic potential of the mycotoxin alternariol in cultured mammalian cells. Food Chem. Toxicol. 44:3 (2006), 398–408.
Marin, S., et al. Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem. Toxicol. 60 (2013), 218–237.
Massart, F., Saggese, G., Oestrogenic mycotoxin exposures and precocious pubertal development. Int. J. Androl. 33:2 (2010), 369–376.
Milicevic, D.R., Skrinjar, M., Baltic, T., Real and perceived risks for mycotoxin contamination in foods and feeds: challenges for food safety control. Toxins (Basel) 2:4 (2010), 572–592.
Molina-Molina, J.M., et al. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol. Appl. Pharmacol. 272:1 (2013), 127–136.
Molina-Molina, J.M., et al. Assessment of estrogenic and anti-androgenic activities of the mycotoxin zearalenone and its metabolites using in vitro receptor-specific bioassays. Food Chem. Toxicol. 74 (2014), 233–239.
Ndossi, D.G., et al. An in vitro investigation of endocrine disrupting effects of trichothecenes deoxynivalenol (DON), T-2 and HT-2 toxins. Toxicol. Lett. 214:3 (2012), 268–278.
O'Brien, J., et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267:17 (2000), 5421–5426.
Payne, J., et al. Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ. Health Perspect. 108:10 (2000), 983–987.
Richter, C.A., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 24:2 (2007), 199–224.
Safe, S.H., et al. Problems for risk assessment of endocrine-active estrogenic compounds. Environ. Health Perspect. 110:Suppl. 6 (2002), 925–929.
Scippo, M.-L., Willemsen, P., Danyi, S., Helbo, V., Muller, M., Martial, J., Maghuin-Rogister, G., Receptor-based screening assays: new perspectives in anti-doping control. Chromatographia 59 (2004), 23–27.
Shi, W., et al. Thyroid hormone disrupting activities associated with phthalate esters in water sources from Yangtze River Delta. Environ. Int. 42 (2012), 117–123.
Sonneveld, E., et al. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol. Sci. 83:1 (2005), 136–148.
Streit, E., et al. Current situation of mycotoxin contamination and co-occurrence in animal feed–focus on Europe. Toxins (Basel) 4:10 (2012), 788–809.
Streit, E., et al. Mycotoxin occurrence in feed and feed raw materials worldwide: long-term analysis with special focus on Europe and Asia. J. Sci. Food Agric. 93:12 (2013), 2892–2899.
Tammer, B., et al. Combined effects of mycotoxin mixtures on human T cell function. Toxicol. Lett. 170:2 (2007), 124–133.
Tatay, E., et al. Interactive effects of zearalenone and its metabolites on cytotoxicity and metabolization in ovarian CHO-K1 cells. Toxicol InVitro 28:1 (2014), 95–103.
Tiemann, U., Danicke, S., In vivo and in vitro effects of the mycotoxins zearalenone and deoxynivalenol on different non-reproductive and reproductive organs in female pigs: a review. Food Addit. Contam. 24:3 (2007), 306–314.
Tomaszewski, J., et al. Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium. Ginekol. Pol. 69:5 (1998), 363–366.
Van Veldhoven, P.P., et al. Do sphingoid bases interact with the peroxisome proliferator activated receptor alpha (PPAR-alpha)?. Cell Signal 12:7 (2000), 475–479.
Versilovskis, A., et al. Simultaneous determination of masked forms of deoxynivalenol and zearalenone after oral dosing in rats by LC-MS/MS. World Mycotoxin J. 5:3 (2012), 303–318.
Willemsen, P., et al. Use of reporter cell lines for detection of endocrine-disrupter activity. Anal. Bioanal. Chem. 378:3 (2004), 655–663.
Wuttke, W., Jarry, H., Seidlova-Wuttke, D., Definition, classification and mechanism of action of endocrine disrupting chemicals. Hormones (Athens) 9:1 (2010), 9–15.
Zinedine, A., et al. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 45:1 (2007), 1–18.
